Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 128 participants.

Also called NCT02322840

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 128 participants (enrolled count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02322840
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Denmark, Finland, France, Greece, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02322840. Allocation not applicable; no masking; primary purpose treatment. Start 2015-04 (actual); primary completion 2022-09-01 (actual). Results posted on 2025-11-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System
Condition
Mitral Valve Insufficiency
Intervention (Device)
Twelve TMVR Implant
Intervention (Device)
Medtronic Intrepid™ Transcatheter Transfemoral Mitral Valve Replacement System
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct02322840
Content hash
554526f251741a632d942119d9cb2fbe266d350c6abec0248d8e881977a9371e